TTAN heads into Tuesday's earnings report with a striking divergence: short sellers have been covering aggressively while call buyers have taken over the options market.
The options signal is the sharpest data point in the setup. The put/call ratio has collapsed to 0.35, nearly 1.4 standard deviations below its 20-day average of 0.55 — the most call-skewed reading in months. That marks a near-complete reversal from late July, when the PCR topped 0.76. Call buyers have been dominant for at least two weeks, despite the stock falling 12% over the past week to $87.92. The gap between deteriorating price action and bullish options positioning makes the setup unusually charged going into the print. Peers sold off hard over the same stretch — ASAN dropped 13.5% on the week, ADBE fell 8.6% — so TTAN's weakness looks partly sector-driven rather than company-specific.
Short sellers are telling a notably less aggressive story than they were a month ago. SI has dropped roughly 27% over the past 30 days to 8.7% of the float — still meaningful, but the direction of travel is clearly toward covering. Borrow conditions support that read: cost to borrow has eased 12% on the week to under 0.5%, and availability at 232% means there is no shortage of shares to lend. The ORTEX short score has also drifted down from 65 in late August to 61.7 now, consistent with a gradual short unwind rather than any squeeze dynamic. The borrow market, in short, looks relaxed.
The bull and bear debate centres on whether TTAN's unit economics are improving fast enough to justify the valuation. Bulls point to raised full-year revenue guidance, a growing enterprise footprint, and strong subscription revenue momentum. The analyst consensus remains firmly positive — the mean price target of $111 implies roughly 26% upside from current levels, and the most recent post-earnings target lifts from Baird and Morgan Stanley both came after the prior quarter's print. Bears flag the trades software market as highly competitive, question long-term cash burn sustainability, and note that trailing profitability metrics are still deeply negative. The PE ratio has expanded sharply — up more than 9 points over the past 30 days — so valuation is becoming harder to ignore at these levels even as the stock has pulled back.
Ownership adds a layer of context worth noting. Co-founders Vahe Kuzoyan and Ara Mahdessian together control roughly 20% of shares, though both have been trimming under pre-arranged 10b5-1 plans — the President sold around $1.1 million worth in mid-August, and CFO Sherry David sold approximately $817,000 on the same timeline. Planned sales carry less signal than discretionary transactions, but the net insider position over 90 days is negative by around $20 million. Meanwhile, BlackRock and FMR (Fidelity) both filed fresh 13G disclosures in July and August respectively, each crossing the 6% threshold — a sign that large passive and active managers are building positions even as insiders reduce.
Tuesday's print will test whether the subscription revenue trajectory and any guidance update can justify the gap between the current price and a Street consensus that still sits more than $23 above where the stock trades today.
See the live data behind this article on ORTEX.
Open TTAN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
